LEISTON SURGERY — All Prescriptions & Medications — Page 4
Practice Code: D83028 | LEISTON, IP16 4ES
Showing results 151-200 of 614
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Hyoscine butylbromide | 305 | 25.5K | £2.0K | +30.9% ▲ |
| Clonazepam | 297 | 13.6K | £1.8K | +90.6% ▲ |
| Mometasone furoate | 292 | 306 | £2.4K | -27.3% ▼ |
| Enalapril maleate | 288 | 8,919 | £407 | +60.3% ▲ |
| Fluticasone propionate (Nasal) | 286 | 690 | £3.1K | +96.4% ▲ |
| 272 | 3,310 | £754 | +30.1% ▲ | |
| Carvedilol | 270 | 13.9K | £490 | +137.9% ▲ |
| Glyceryl trinitrate | 270 | 274 | £669 | +14.2% ▲ |
| Lorazepam | 267 | 5,897 | £740 | +87.3% ▲ |
| Fludrocortisone acetate | 267 | 9,513 | £1.5K | +153.1% ▲ |
| 263 | 1,075 | £1.9K | +498.2% ▲ | |
| Brinzolamide | 262 | 1,590 | £1.2K | +101.7% ▲ |
| Risperidone | 252 | 10.5K | £1.2K | -0.4% vs avg |
| Paroxetine hydrochloride | 249 | 8,606 | £315 | +33.4% ▲ |
| Topiramate | 243 | 11.8K | £966 | +36.7% ▲ |
| Trazodone hydrochloride | 240 | 13.3K | £556 | +17.4% ▲ |
| Cyclizine hydrochloride | 235 | 11.3K | £401 | +45.7% ▲ |
| Medroxyprogesterone acetate | 233 | 233 | £1.3K | +93.0% ▲ |
| Umeclidinium bromide | 232 | 232 | £6.0K | +276.4% ▲ |
| Estriol | 232 | 3,309 | £1.9K | +9.0% ▲ |
| Clobetasol propionate | 231 | 9,205 | £854 | +69.3% ▲ |
| Ibuprofen | 228 | 22.9K | £549 | -55.2% ▼ |
| 220 | 229 | £10.0K | -29.2% ▼ | |
| Prochlorperazine maleate | 220 | 6,405 | £426 | +8.8% ▲ |
| Aciclovir | 220 | 9,426 | £451 | +47.9% ▲ |
| 220 | 6,356 | £2.1K | +184.5% ▲ | |
| Carbamazepine | 218 | 18.4K | £1.2K | -26.5% ▼ |
| Glycopyrronium bromide | 215 | 6,450 | £5.6K | +476.9% ▲ |
| Dorzolamide and timolol | 213 | 6,805 | £3.7K | +48.8% ▲ |
| Donepezil hydrochloride | 206 | 6,069 | £233 | -33.2% ▼ |
| Fentanyl | 198 | 6,467 | £29.9K | +93.3% ▲ |
| Oxybutynin | 198 | 11.8K | £388 | +3.9% ▲ |
| Escitalopram | 196 | 6,104 | £361 | -31.1% ▼ |
| Fluticasone furoate/vilanterol | 195 | 195 | £4.4K | +26.0% ▲ |
| Nystatin | 193 | 6,120 | £348 | +91.5% ▲ |
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 193 | 1.5M | £16.7K | +341.1% ▲ |
| 192 | 922 | £539 | +87.9% ▲ | |
| 187 | 190 | £1.1K | -20.8% ▼ | |
| Clobetasone butyrate | 185 | 8,560 | £1.1K | -9.4% ▼ |
| Vortioxetine | 184 | 4,393 | £4.1K | +165.1% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 181 | 26.5K | £1.9K | -19.9% ▼ |
| Pioglitazone hydrochloride | 181 | 5,050 | £235 | +104.7% ▲ |
| Nortriptyline | 180 | 8,841 | £353 | +23.7% ▲ |
| Methenamine hippurate | 177 | 11.3K | £3.0K | +94.6% ▲ |
| Midodrine hydrochloride | 176 | 14.1K | £2.7K | +261.2% ▲ |
| Lidocaine hydrochloride | 175 | 1,902 | £2.0K | +1.4% vs avg |
| Loratadine | 174 | 7,282 | £158 | -16.7% ▼ |
| Tadalafil | 174 | 2,238 | £401 | +2.3% ▲ |
| Nifedipine | 173 | 8,998 | £2.3K | -7.7% ▼ |
| Etoricoxib | 173 | 5,264 | £1.1K | +114.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.